CPMV — Mosaic Immunoengineering Cashflow Statement
0.000.00%
Last trade - 00:00- $2.91m
- $4.07m
Annual cashflow statement for Mosaic Immunoengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.798 | -1.06 | -3.68 | -2.38 | -1.01 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.092 | 0.075 | 1.49 | 0.046 | -0.369 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.054 | -0.028 | 1.52 | 1.64 | 0.879 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -0.761 | -0.987 | -0.679 | -0.69 | -0.497 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.573 | 0.75 | 0.028 | 0.343 | 0.433 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.573 | 0.75 | 0.028 | 0.343 | 0.433 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 0.525 | 0.342 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.33 | -0.237 | -0.127 | -0.005 | -0.064 |